These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37483310)

  • 21. Genistein Restricts the Epithelial Mesenchymal Transformation (EMT) and Stemness of Hepatocellular Carcinoma via Upregulating miR-1275 to Inhibit the EIF5A2/PI3K/Akt Pathway.
    Yang X; Jiang W; Kong X; Zhou X; Zhu D; Kong L
    Biology (Basel); 2022 Sep; 11(10):. PubMed ID: 36290289
    [No Abstract]   [Full Text] [Related]  

  • 22. Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin α2 (KPNA2) and inactivate p53 signaling.
    Tang G; Zhao H; Xie Z; Wei S; Chen G
    Bioengineered; 2022 Mar; 13(3):7829-7846. PubMed ID: 35291921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML; Zhang Y; Ma LT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.
    Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
    J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC01608 activated by YY1 facilitate hepatocellular carcinoma progression by modulating the EGFR/ERK axis.
    Han M; Liu F; Li X; Zhang H; Pan Y; Liu Y; Zhu H; Liang H; Chen X; Liao Z; Zhang Z; Zhang B
    Liver Int; 2023 Feb; 43(2):471-489. PubMed ID: 36385489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
    Li W; Jiang Y; Pan Q; Yang G
    Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis.
    Yang G; Zhou L; Xu Q; Meng F; Wan Y; Meng X; Wang L; Zhang L
    Cell Cycle; 2020 Oct; 19(19):2519-2529. PubMed ID: 32936716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.
    Liang Z; Li X; Duan F; Song L; Wang Z; Li X; Yang P; Li L
    Hum Cell; 2022 Jan; 35(1):299-309. PubMed ID: 34784010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
    Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
    Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 32. Circ_0001175 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis by Regulating miR-130a-5p.
    Li L; He K; Chen S; Wei W; Tian Z; Tang Y; Xiao C; Xiang G
    Onco Targets Ther; 2020; 13():13315-13327. PubMed ID: 33408482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p.
    Chen PP; Zhang ZS; Wu JC; Zheng JF; Lin F
    Cell Signal; 2021 Aug; 84():109992. PubMed ID: 33774129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p/CELF1 axis.
    Liu C; Wang H; Tang L; Huang H; Xu M; Lin Y; Zhou L; Ho L; Lu J; Ai X
    Life Sci; 2021 Jun; 275():119288. PubMed ID: 33667514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of hepatocellular carcinoma through inhibiting WEE1.
    Jiang SP; Li ZR
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2028-2037. PubMed ID: 30915746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
    Wang JT; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-96-5p induces the epithelial-mesenchymal transition to promote the metastasis of hepatocellular carcinoma by post-transcriptionally downregulating Talin 1.
    Tang H; Liu Y; Cheng W; He Z; Zhou N
    Int J Clin Exp Pathol; 2019; 12(5):1897-1908. PubMed ID: 31934013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop.
    Liu DL; Lu LL; Dong LL; Liu Y; Bian XY; Lian BF; Xie L; Wen D; Gao DM; Ke AW; Fan J; Wu WZ
    Theranostics; 2020; 10(8):3668-3683. PubMed ID: 32206115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.